What’s Next For Ionis Pharmaceuticals Stock After A 14% Fall?
- Wednesday, October 20, 2021, 7:16
- Market
- Add a comment
The stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, plunged 14% in yesterday’s trade to its five year low levels of $30, while it is down 19% over the last one month…
About the Author
admin123 has written 23527 stories on this site.
